0001493152-22-017152.txt : 20220617 0001493152-22-017152.hdr.sgml : 20220617 20220617160549 ACCESSION NUMBER: 0001493152-22-017152 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210825 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Agah Ramtin CENTRAL INDEX KEY: 0001862617 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40738 FILM NUMBER: 221023778 MAIL ADDRESS: STREET 1: 4546 EL CAMINO REAL STREET 2: SUITE 223 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RenovoRx, Inc. CENTRAL INDEX KEY: 0001574094 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271448452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 W. SANTA CLARA STREET, SUITE 900 CITY: SAN JOSE STATE: CA ZIP: 95110 BUSINESS PHONE: 408-800-2649 MAIL ADDRESS: STREET 1: 333 W. SANTA CLARA STREET, SUITE 900 CITY: SAN JOSE STATE: CA ZIP: 95110 3/A 1 ownership.xml X0206 3/A 2021-08-25 2021-08-25 0 0001574094 RenovoRx, Inc. RNXT 0001862617 Agah Ramtin C/O RENOVORX, INC. 4546 EL CAMINO REAL, SUITE B1 LOS ALTOS, CA 94022 1 1 1 0 Chief Medical Officer Convertible Notes 2022-04-30 Common Stock 1295 D Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, will automatically convert into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share. This report on Form 3/A is filed to include the reported convertible notes in Table 2. Due to an administrative error, the notes were omitted from the Form 3 filed with the SEC on August 25, 2021. /s/ Ramtin Agah, MD 2022-06-17